Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment
Clinical trial NCT01863745 · COMPLETED
Trial details
- NCT number
- NCT01863745
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-25
- Primary completion
- 2023-10-02
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.